Alcohol and Beverage Industry
Emerge attorneys have represented businesses in the alcohol and beverage industry, including wineries, breweries, distilleries, restaurants, bars, movie theaters, golf courses, and gas stations. We can help you vet new locations, acquire existing locations, and apply for the appropriate liquor license. We also provide training to comply with applicable rules and regulations, prepare operating procedures, submit renewals, and keep clients protected in the event of any potential violations or administrative hearings.
See our Craft Beverage Industry page for more information.
Emerge Law Group is highly experienced in the cannabis industry. We have helped many clients obtain state licenses and local permits to operate cannabis businesses throughout California, Oregon, and Washington. We regularly help clients with:
- Operating procedures
- Employee trainings
- Changes of ownership
- Handling violations
- Other administrative hearings
Cannabis laws and rules are also regularly changing. Members of our team are dedicated to attending legislative hearings, state agency and local city and county meetings to stay up-to-date on any new changes and how to adjust to any new changes.
See our Cannabis Industry page for more information.
Emerge Law Group is a leader in the psychedelics industry. There is tremendous excitement about the potential for psychedelic drugs to benefit a wide variety of populations, including veterans struggling with PTSD and terminally ill patients suffering with anxiety and depression. Until recently, psychedelic substances have been accessible only in the underground; they are illegal under state and federal law to manufacture, distribute, or possess. These substances have, since 1970, been treated as having no legitimate medical use, and no commercial application. As such, businesses have not invested in this area or required legal services, outside of the criminal context.
Today, psychedelics are proceeding toward legalization on multiple paths. Researchers in a multitude of clinical studies are proving the medical safety and efficacy of these medicines, with the objective of changing the treatment of these substances under the federal Controlled Substances Act, opening legal access to them. Private and public companies are now actively raising money to develop intellectual property and capitalize on the market opportunities associated with psychedelic drugs. Opportunities to be early actors in this new arena are tremendous.
See our Psychedelics Industry page for more information.